V. Mouraviev

K. Palmer, V. Patel, V. Mouraviev, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Cigarette smoking is associated with advanced renal cell carcinoma.

D. Moreira, V. Mouraviev, T. Polascik, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevalence and risk factors of contralateral extraprostatic extension in men undergoing radical prostatectomy for unilateral disease at biopsy: A global multi-institutional experience.

F. Saad, D. Albala, M. Latour, 2015, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Preoperative Predictors of Pathologic Stage T2a in Low-Risk Prostate Cancer: Implications for Focal Therapy

J. Moul, V. Mouraviev, T. Polascik, 2012, Urologia Internationalis.

Current status of pelvic lymph node dissection in prostate cancer

D. Albala, V. Mouraviev, I. Aleksić, 2014, Journal of Robotic Surgery.

Editorial Comment to Manually controlled targeted prostate biopsy with real‐time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: An early experience

V. Mouraviev, D. Telonis, 2015, International journal of urology : official journal of the Japanese Urological Association.

Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: the predictive role of age and prostate-specific antigen.

J. Moul, D. Albala, J. Madden, 2008, Urology.

PSA Screening for the African American Male: When and Why?

D. Albala, V. Mouraviev, I. Aleksić, 2013 .

The role of caveolin-1 in androgen insensitive prostate cancer.

T. Wheeler, M. Ittmann, B. Miles, 2002, The Journal of urology.

Prostate biopsy in selecting candidates for hemiablative focal therapy.

V. Mouraviev, T. Polascik, J. Rassweiler, 2010, Journal of endourology.

Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model

T. Timme, V. Mouraviev, H. Kumon, 2006, Cancer Gene Therapy.

Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes?

J. Moul, D. Albala, V. Mouraviev, 2009, Urology.

Can prostate-specific antigen and prostate-specific antigen velocity be used for prostate cancer screening in men older than 70 years?

J. Moul, V. Mouraviev, T. Polascik, 2008, Urology.

Tumor volume, tumor percentage involvement or prostate volume: Which is predictive of PSA recurrence?

J. Moul, D. Albala, V. Mouraviev, 2009 .

Association between percentage of tumor involvement and Gleason score upgrading in low-risk prostate cancer

J. Moul, V. Mouraviev, T. Polascik, 2012, Medical Oncology.

MP07-17 CLINICAL VALIDATION OF A LIVE-CELL PHENOTYPIC BIOMARKER - BASED DIAGNOSTIC ASSAY FOR THE PREDICTION OF ADVERSE PATHOLOGY IN PROSTATE CANCER

Matt J. Whitfield, Wendell R. Su, Michael S. Manak, 2016 .

A live cell microfluidics device utilizing phenotypic biomarkers for prostate cancer.

Matt J. Whitfield, Wendell R. Su, Michael S. Manak, 2016 .

Novel live tumor cell diagnostic test utilizing biophysical and molecular biomarkers to assess local, advanced, and metastatic prostate cancer.

Matt J. Whitfield, Wendell R. Su, Michael S. Manak, 2015 .

Preoperative predictors of pathologic stage T2a and pathologic Gleason score ≤ 6 in men with clinical low-risk prostate cancer treated with radical prostatectomy: reference for active surveillance

J. Moul, V. Mouraviev, T. Polascik, 2013, Medical Oncology.

6B-2 Visualizing the Anatomic Structures of Human Prostates Using Acoustic Radiation Force Impulse (ARFI)Imaging

K. Nightingale, L. Zhai, J. Madden, 2007, 2007 IEEE Ultrasonics Symposium Proceedings.

Primary Cryotherapy for High-Grade Clinically Localized Prostate Cancer: Oncologic and Functional Outcomes from the COLD Registry.

J. Jones, A. Ross, V. Mouraviev, 2016, Journal of endourology.

Technical Innovations to Optimize Early Return of Erectile Function

V. Patel, V. Mouraviev, G. Ogaya‐Pinies, 2016 .

Ureteropelvic junction obliteration resulting in nephrectomy after radiofrequency ablation of small renal cell carcinoma.

G. Raj, V. Mouraviev, T. Polascik, 2007, Urology.

Sipuleucel-T for the Treatment of Patients With Metastatic Castrate-resistant Prostate Cancer: Considerations for Clinical Practice.

D. Albala, V. Mouraviev, C. Pieczonka, 2015, Reviews in urology.

The Rationale for Optimal Combination Therapy With Sipuleucel-T for Patients With Castration-resistant Prostate Cancer.

D. Albala, M. Emberton, V. Mouraviev, 2014, Reviews in urology.

Transurethral Microwave Therapy

D. Albala, V. Mouraviev, I. Aleksić, 2015 .

A meaningful legacy: urologists as Nobel Prize laureates.

M. Gleave, V. Mouraviev, 2003, The Canadian journal of urology.

Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer model.

T. Timme, T. Thompson, V. Mouraviev, 2003, Cancer research.

Persistent contrast enhancement several months after laparoscopic cryoablation of the small renal mass may not indicate recurrent tumor.

R. Nelson, V. Mouraviev, T. Polascik, 2008, Journal of endourology.

Urothelial sloughing with obstruction after laparoscopic cryoablation of small renal carcinoma in solitary kidney.

V. Mouraviev, T. Polascik, J. Mayes, 2008, Urology.

Short Term Clinical Outcome after Laparoscopic Cryoablation of the Renal Tumor ≤ 3.5 cm

V. Mouraviev, T. Polascik, J. Mayes, 2007, Technology in cancer research & treatment.

Comparative financial analysis of minimally invasive surgery to open surgery for small renal tumours < or =3.5 cm: a single institutional experience.

D. Albala, V. Mouraviev, T. Polascik, 2007, European urology.

Mn-Porphyrins as Novel Molecular MRI Contrast Agents

T. Venkatraman, C. Lascola, V. Mouraviev, 2011 .

The 3DBiopsy Prostate Biopsy System: Preclinical Investigation of a Needle, Actuator, and Specimen Collection Device Allowing Sampling of Individualized Prostate Lengths Between 20 and 60 mm.

M. Lucia, E. Crawford, N. Stone, 2017, Urology.

Transrectal Ultrasound-guided Versus Transperineal Mapping Prostate Biopsy: Complication Comparison.

E. Crawford, N. Stone, V. Mouraviev, 2018, Reviews in urology.

A HEAD TO HEAD COMPARATIVE PHASE II TRIAL OF STANDARD URINE CULTURE AND SENSITIVITY VERSUS DNA NEXT GENERATION SEQUENCING TESTING FOR URINARY TRACT INFECTIONS: PNFLBA‐02

V. Mouraviev, M. McDonald, Mark E. Johnson, 2017 .

A Head-to-Head Comparative Phase II Study of Standard Urine Culture and Sensitivity Versus DNA Next-generation Sequencing Testing for Urinary Tract Infections.

D. Albala, V. Mouraviev, M. McDonald, 2017, Reviews in urology.

Integrin Involvement in Freeze Resistance of Androgen-Insensitive Prostate Cancer

V. Mouraviev, T. Polascik, A. Gage, 2010, Prostate Cancer and Prostatic Diseases.

Pathologic Rationale for Focal Therapy of Prostate Cancer: Elucidating Tumor Characteristics and Biology

A. Villers, R. Montironi, T. Wheeler, 2017 .

Contemporary results of focal therapy for prostate cancer using cryoablation.

V. Mouraviev, T. Polascik, T. Johansen, 2010, Journal of endourology.

Focal Targeted Therapy Will Be a Future Treatment Modality for Early Stage Prostate Cancer

V. Mouraviev, T. Polascik, J. Rosette, 2009 .

Nerve-sparing focal cryoablation of prostate cancer

V. Mouraviev, T. Polascik, J. Mayes, 2009, Current opinion in urology.

Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer.

T. Timme, T. Thompson, V. Mouraviev, 2003, Human gene therapy.

A Clinician’s Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III)

E. Crawford, S. Freedland, A. Ross, 2019, The Journal of urology.

Rectourethral fistula after combination radiotherapy for prostate cancer.

M. Anscher, G. Raj, V. Mouraviev, 2007, Urology.

Cadaveric anatomy of pelvic fracture urethral distraction injury: most injuries are distal to the external urinary sphincter.

R. Santucci, V. Mouraviev, 2005, The Journal of urology.

The treatment of posterior urethral disruption associated with pelvic fractures: comparative experience of early realignment versus delayed urethroplasty.

R. Santucci, V. Mouraviev, M. Coburn, 2005, The Journal of urology.

Zoledronic acid in the management of metastatic bone disease

V. Mouraviev, T. Polascik, 2008, Therapeutics and clinical risk management.

Utilization of 111In‐Capromab pendetide SPECT‐CT for detecting seminal vesicle invasion with recurrent prostate cancer after primary in situ therapy

J. Madden, V. Mouraviev, T. Polascik, 2009, International journal of urology : official journal of the Japanese Urological Association.

Predicting unilateral prostate cancer on routine diagnostic biopsy: sextant vs extended

V. Mouraviev, T. Polascik, M. Kimura, 2010, BJU international.

Predicting occult multifocality of renal cell carcinoma.

D. Albala, D. Moreira, J. Madden, 2010, European urology.

Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy

V. Mouraviev, T. Polascik, T. Satoh, 2010, BJU international.

Pathologic stage T2a and T2b prostate cancer in the recent prostate‐specific antigen era: Implications for unilateral ablative therapy

J. Moul, J. Madden, V. Mouraviev, 2008, The Prostate.

Management of Infective Complications Following Prostate Biopsy

V. Mouraviev, T. Johansen, Catherine Pereira, 2016 .

Novel Metalloporphyrins as Molecular MR Contrast Agents

T. Venkatraman, C. Lascola, V. Mouraviev, 2009 .

Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model

T. Timme, T. Thompson, V. Mouraviev, 2004, Cancer Gene Therapy.

Urinary bladder cancer: role of MR imaging.

Sadhna Verma, S. Verma, S. Prasad, 2012, Radiographics : a review publication of the Radiological Society of North America, Inc.

The use of 1,25α dihydroxyvitamin D3 as a cryosensitizing agent in a murine prostate cancer model

V. Mouraviev, T. Polascik, A. Gage, 2010, Prostate Cancer and Prostatic Diseases.

Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry

F. Bruyère, V. Mouraviev, Z. Tandoğdu, 2019, World Journal of Urology.

Patient selection for hemiablative focal therapy of prostate cancer

J. Moul, J. Madden, V. Mouraviev, 2009, Cancer.

Roadmap for Focal Therapy

V. Mouraviev, T. Polascik, 2013 .

Focal Therapy: Prostate Hemiablation as the First Historical Treatment Model for Focal Therapy of Early Stage Prostate Cancer

V. Mouraviev, T. Polascik, 2012 .

Focal therapy for prostate cancer

Thomas J. Polascik, V. Mouraviev, T. Polascik, 2008, Current opinion in urology.

Pathologic basis of focal therapy for early-stage prostate cancer

V. Mouraviev, T. Polascik, J. Mayes, 2009, Nature Reviews Urology.

The effect of cryoablation on the histologic interpretation of intraoperative biopsy of small clear cell renal carcinoma and renal oncocytoma.

J. Madden, V. Mouraviev, T. Polascik, 2008, Journal of endourology.

Current status of minimally invasive ablative techniques in the treatment of small renal tumours.

Steven Joniau, V. Mouraviev, T. Polascik, 2007, European urology.

1257 SMALL RENAL MASSES: SHOULD CURRENT TREATMENT STRATEGY BE REAPPRAISED?

D. Albala, V. Mouraviev, T. Polascik, 2011 .

Fournier's Gangrene Following Penile Self-injection with Cocaine

V. Mouraviev, S. Pautler, W. P. Hayman, 2002, Scandinavian journal of urology and nephrology.

The human gastrointestinal microbiota and prostate cancer development and treatment

V. Mouraviev, M. Dixon, M. Stefil, 2019, Investigative and clinical urology.

Diffusion of Robotic Technology Into Urologic Practice has Led to Improved Resident Physician Robotic Skills.

Vipul R Patel, David D Thiel, V. Patel, 2017, Journal of surgical education.

Current status of various neurovascular bundle-sparing techniques in robot-assisted radical prostatectomy

V. Patel, V. Mouraviev, S. Samavedi, 2016, Journal of Robotic Surgery.

Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening.

J. Moul, D. Albala, P. Dahm, 2007, The Journal of urology.

Altered male physiologic function after surgery for prostate cancer: couple perspective.

V. Mouraviev, T. Polascik, T. Krupski, 2009, International braz j urol : official journal of the Brazilian Society of Urology.

Evaluation of a novel precision template‐guided biopsy system for detecting prostate cancer

A. Kibel, G. Andriole, S. Taneja, 2008, BJU international.

Rapid and Short-term Extracellular Matrix-mediated In Vitro Culturing of Tumor and Nontumor Human Primary Prostate Cells From Fresh Radical Prostatectomy Tissue.

Michael S. Manak, J. Varsanik, B. Hogan, 2017, Urology.

Safety of selective nerve sparing in high risk prostate cancer during robot-assisted radical prostatectomy

V. Patel, V. Mouraviev, S. Samavedi, 2017, Journal of Robotic Surgery.

Salvage cryoablation for locally recurrent prostate cancer following primary radiotherapy.

V. Mouraviev, P. Spiess, Philippe E. Spiess, 2012, European urology.

Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience.

J. Moul, D. Albala, V. Mouraviev, 2007, Urology.

Clinical predictors of renal mass pathological features

D. Albala, J. Madden, V. Mouraviev, 2011, BJU international.

Neoadjuvant therapy in localized prostate cancer before surgery and radiotherapy.

V. Mouraviev, 1998, Current opinion in urology.

Apical surgical margins status in robot-assisted laparoscopic radical prostatectomy does not depend on disease characteristics.

Michael N. Ferrandino, D. Albala, J. Madden, 2012, Journal of endourology.

Clinical Proof-of-concept of a Novel Platform Utilizing Biopsy-derived Live Single Cells, Phenotypic Biomarkers, and Machine Learning Toward a Precision Risk Stratification Test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3 + 3 and 3 + 4).

Jonathan S Varsanik, Michael S. Manak, J. Varsanik, 2019, Urology.

Prostate cancer: an evolving paradigm.

J. Moul, V. Mouraviev, T. Polascik, 2010, Journal of endourology.

Vitamin D3 cryosensitization increases prostate cancer susceptibility to cryoablation via mitochondrial‐mediated apoptosis and necrosis

Anthony T. Robilotto, V. Mouraviev, T. Polascik, 2012, BJU international.

Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications.

D. Downey, J. Chin, V. Mouraviev, 2001, The Journal of urology.

Impact of primary Gleason grade on risk stratification for Gleason score 7 prostate cancers.

J. Moul, V. Mouraviev, W. Lee, 2012, International journal of radiation oncology, biology, physics.

Outcomes of salvage prostate cryotherapy stratified by pre-treatment PSA: update from the COLD registry

V. Mouraviev, P. Spiess, L. Pisters, 2013, World Journal of Urology.

Tumor size and endophytic growth pattern affect recurrence rates after laparoscopic renal cryoablation.

V. Mouraviev, T. Polascik, M. Kimura, 2009, Urology.

Utility of a 3-Dimensional Transrectal Ultrasound-guided Prostate Biopsy System for Prostate Cancer Detection

J. Moul, J. Madden, V. Mouraviev, 2009, Technology in cancer research & treatment.

Prostate Specific Antigen Nadir of 0.1 or Less Is a Predictor of Treatment Success in Men Undergoing Salvage Whole Prostate Gland Cryoablation.

A. Ross, V. Mouraviev, T. Polascik, 2017, Journal of endourology.

Understanding the pathological features of focality, grade and tumour volume of early‐stage prostate cancer as a foundation for parenchyma‐sparing prostate cancer therapies: active surveillance and focal targeted therapy

D. Bostwick, A. Villers, R. Montironi, 2011, BJU international.

Pathologic Basis for Focal Therapy: Understanding Cancer Grade, Volume, and Spatial Location

D. Bostwick, A. Villers, R. Montironi, 2013 .

The feasibility of multiparametric magnetic resonance imaging for targeted biopsy using novel navigation systems to detect early stage prostate cancer: the preliminary experience.

S. Verma, V. Mouraviev, J. Donovan, 2013, Journal of endourology.

Pathological T2 sub‐divisions as a prognostic factor in the biochemical recurrence of prostate cancer

J. Moul, V. Mouraviev, T. Polascik, 2010, BJU international.

Changes in Gleason score grading and their effect in predicting outcome after radical prostatectomy.

J. Moul, J. Madden, V. Mouraviev, 2009, Urology.

A pretreatment nomogram for prediction of biochemical failure after primary cryoablation of the prostate

V. Mouraviev, T. Polascik, Changhong Yu, 2015, The Prostate.

Mn porphyrins as novel molecular magnetic resonance imaging contrast agents.

T. Amrhein, T. Venkatraman, C. Lascola, 2012, Journal of endourology.

Adjuvant versus salvage radiation therapy for prostate cancer and the risk of death

A. D'Amico, Ming-Hui Chen, J. Moul, 2010, BJU international.

Avoiding surgery in prostate cancer patients with low-risk disease

V. Mouraviev, T. Polascik, 2008 .

Complications of laparoscopic and percutaneous renal cryoablation in a single tertiary referral center.

R. Nelson, D. Albala, V. Mouraviev, 2010, European urology.

Focal therapy for prostate cancer is a reasonable treatment option in properly selected patients.

V. Mouraviev, T. Polascik, 2009, Urology.

Predictors of biochemical failure in patients undergoing prostate whole‐gland salvage cryotherapy: a novel risk stratification model

V. Mouraviev, P. Spiess, L. Pisters, 2013, BJU international.

Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancer.

J. Moul, M. Anscher, V. Mouraviev, 2008, International journal of radiation oncology, biology, physics.

Urology residents experience comparable workload profiles when performing live porcine nephrectomies and robotic surgery virtual reality training modules

J. Pow-Sang, V. Patel, L. Su, 2016, Journal of Robotic Surgery.

Analysis of Laterality and Percentage of Tumor Involvement in 1386 Prostatectomized Specimens for Selection of Unilateral Focal Cryotherapy

J. Madden, V. Mouraviev, T. Polascik, 2007, Technology in cancer research & treatment.

Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology.

V. Mouraviev, T. Polascik, J. Mayes, 2007, Urology.

Prostate cancer: the new landscape

J. Moul, V. Mouraviev, T. Polascik, 2009, Current opinion in urology.

Comparison of prostate‐specific antigen recurrence‐free survival in a contemporary cohort of patients undergoing either radical retropubic or robot‐assisted laparoscopic radical prostatectomy

J. Moul, S. Freedland, V. Mouraviev, 2008, BJU international.

Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy

V. Patel, V. Mouraviev, S. Samavedi, 2017, Journal of Robotic Surgery.

417 PREDICTING OCCULT MULTIFOCALITY OF RENAL CELL CARCINOMA

D. Albala, D. Moreira, V. Mouraviev, 2010 .

The rise of ablative technologies for treating the small renal mass.

V. Mouraviev, T. Polascik, 2007, European urology.

Complications and postoperative events after cryosurgery for prostate cancer

V. Mouraviev, T. Polascik, M. Kimura, 2012, BJU international.

Andrologic Sequelae in Prostatitis Patients

V. Mouraviev, J. Syed, 2016 .

From whole-gland to targeted cryoablation for the treatment of unilateral or focal prostate cancer.

V. Mouraviev, T. Polascik, J. Mayes, 2008, Oncology.

Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer

A. Partin, A. Partin, A. Ross, 2015, Prostate Cancer and Prostatic Disease.

Acoustic radiation force impulse imaging of human prostates ex vivo.

Kathryn R Nightingale, Mark L Palmeri, Liang Zhai, 2010, Ultrasound in medicine & biology.

Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer?

J. Madden, V. Mouraviev, T. Polascik, 2011, Urologic oncology.

Robotic Radical Prostatectomy: Complex Case Management

V. Patel, V. Mouraviev, G. Ogaya‐Pinies, 2017 .

Predicting biopsy-proven prostate cancer recurrence following cryosurgery.

V. Mouraviev, T. Polascik, M. Tsivian, 2012, Urologic oncology.

Should elderly men be screened for prostate cancer

J. Moul, V. Mouraviev, 2008 .

Three-dimensional acoustic radiation force impulse (ARFI) imaging of human prostates in vivo

K. Nightingale, L. Zhai, J. Madden, 2008, 2008 IEEE Ultrasonics Symposium.

Update on cryotherapy for prostate cancer in 2006

V. Mouraviev, T. Polascik, Thomas J Polascik, 2006, Current opinion in urology.

Focal therapy for prostate cancer: pathologic basis

J. Madden, V. Mouraviev, 2009, Current opinion in urology.

Salvage cryoablation for locally recurrent prostate cancer following primary radiotherapy.

V. Mouraviev, Philippe E. Spiess, J. Jones, 2012, European urology.

Complications and postoperative events after cryosurgery for prostate cancer

V. Mouraviev, T. Polascik, M. Kimura, 2012, BJU international.

Use of 111in-capromab pendetide immunoscintigraphy to image localized prostate cancer foci within the prostate gland.

J. Madden, V. Mouraviev, T. Polascik, 2009, The Journal of urology.

Biopsy accuracy in identifying unilateral prostate cancer depends on prostate weight.

J. Moul, D. Moreira, V. Mouraviev, 2012, Urologic oncology.

On-demand use of erectile aids in men with preoperative erectile dysfunction treated by whole gland prostate cryoablation

D. Moreira, V. Mouraviev, T. Polascik, 2011, International Journal of Impotence Research.

Focal therapy for prostate cancer is a reasonable treatment option in properly selected patients.

V. Mouraviev, T. Polascik, 2009, Urology.

Focal therapy for prostate cancer

V. Mouraviev, T. Polascik, 2008, Current opinion in urology.

Role of vitamin D(3) as a sensitizer to cryoablation in a murine prostate cancer model: preliminary in vivo study.

V. Mouraviev, T. Polascik, J. Baust, 2010, Urology.

Concordance in the perception of couples recovering from primary surgical treatment of prostate cancer

V. Mouraviev, T. Polascik, T. Polascik, 2009, International Journal of Impotence Research.

111-In-capromab pendetide imaging using hybrid-γ camera-computer tomography technology is not reliable in detecting seminal vesicle invasion in patients with prostate cancer.

J. Madden, V. Mouraviev, T. Polascik, 2012, Urologic oncology.

Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry

F. Bruyère, V. Mouraviev, Z. Tandoğdu, 2019, World Journal of Urology.

Clinical predictors of renal mass pathological features

D. Albala, J. Madden, V. Mouraviev, 2011, BJU international.

Adult Urology Rectourethral Fistula After Combination Radiotherapy for Prostate Cancer

M. Anscher, G. Raj, V. Mouraviev, 2007 .